Introduction {#s1}
============

Head and neck cancer (HNC) is now the fifth most common type of cancer in the world \[[@B1]\], with approximately 434,000 new patients diagnosed annually worldwide \[[@B2]\]. Most of the cases involving new patients occur in economically developing countries, such as India, Brazil, and Thailand \[[@B3],[@B4]\]. HNC is generally divided into three groups: oral cavity, pharynx, and larynx. Evolvement of HNC is a multifactorial process associated with various risk factors. Accumulative evidence indicates that tobacco smoking, drinking alcohol, and chewing betel quid are three major risk factors for HNC \[[@B5],[@B6]\]. These environmental carcinogens may induce a defective DNA damage response, which may lead to apoptosis or may result in genomic instability and un-regulated (proliferative) cell growth \[[@B7]--[@B9]\].

The DNA repair system aims to maintain genomic integrity, and constantly challenge the environmental insults and replication errors. Therefore, the alteration of DNA repair genes could increase the risk of carcinoma in the head and neck \[[@B10]\]. Three important DNA repair pathways, including nucleotide excision repair (NER), base excision repair (BER), and double strand break (DSB), are involved in this process. The x-ray repair cross-complementing group 1 (XRCC1) involved in the BER pathway is thought to play a key role in protecting the genome from a variety of risk factors. Three common single nucleotide polymorphisms in the XRCC1 gene, including Arg194Trp (C to T substitution at exon 6 resulting in an Arg to Trp amino acid change), Arg280His (G to A substitution at exon 9 resulting in an Arg to His amino acid change), and Arg399Gln (G to A substitution at exon 10 resulting in an Arg to Gln amino acid change) are most commonly tested in many studies that have examined different populations.

Multiple studies have evaluated the association of HNC risk with polymorphism in the DNA repair genes XRCC1 Arg194Trp, XRCC1 Arg280His, and XRCC1 Arg399Gln. However, these results are inconsistent. While no association between XRCC1 polymorphisms and HNC risk was demonstrated in some studies \[[@B11],[@B12]\], but Ramachandran et al. \[[@B13]\] and Olshan et al. \[[@B14]\] found a relationship between XRCC1 Arg194Trp and Arg399Gln polymorphisms and the risk of HNC. Olshan et al. \[[@B14]\] performed a stratified analysis to estimate the interaction between XRCC1 polymorphisms and smoking, suggesting that the Arg194Trp and Arg399Gln variants of XRCC1 were associated with the risk of HNC in those cases, but no association was found in Kumar's research \[[@B15]\]. Although Flores-Obando et al. \[[@B16]\] performed a meta-analysis in 2010 on the relationship between XRCC1 polymorphisms and the risk of HNC, subgroup analyses of smoking and genotyping method were not performed. Considering these conflicting results, we conducted an updated meta-analysis to deduce a reasonable conclusion about the relationship between XRCC1 polymorphisms and HNC risk. Subgroup analyses concerning ethnicity, smoking, site of HNC, publication year, and genotyping method were performed. Therefore, the current meta-analysis has a greater ability power to derive a more accurate conclusions than previous meta-analyses.

Materials and Methods {#s2}
=====================

Search strategy {#s2.1}
---------------

A systematic and electronic search of the PubMed, EMBASE, Web of Science, and China National Knowledge Infrastructure (CNKI) databases was performed to identify studies using combinations of the following search terms: "head and neck", "oral", "pharynx", "larynx", "nasopharynx", "cancer", "tumor", "carcinoma", "x-ray repair cross complementing group 1", "XRCC1", "Arg194Trp", "Arg280His", "Arg399Gln", "polymorphism", and "variation". All of the studies were published from their earliest entry points to March 2013.

Selection {#s2.2}
---------

All of the studies met the following inclusion criteria: (1) published in English; (2) examined case-control studies estimating the relationship between XRCC1 polymorphism and the risk of HNC; (3) described genotype frequencies; (4) genotype distribution in controls must be in Hardy-Weinberg equilibrium (HWE); and (5) when duplicated studies were published by the same author obtained from the same patient sample, only the most complete publication study was included in this meta-analysis. Unpublished reports and abstracts were not considered.

Data extraction {#s2.3}
---------------

The data were collected according to a standard protocol. The following information was extracted from each study: name of the first author, year of publication, country, genotyping methods, ethnicity and source of the cases and controls, characteristics of the sample population, and the genotype numbers from the cases and the controls.

Statistical analysis {#s2.4}
--------------------

We first tested for deviations from the Hardy-Weinberg equilibrium (HWE) in the control groups using the goodness-of-fit test (Chi-square test or Fisher exact test). The odds ratio (OR) with a corresponding 95% confidence interval (CI) was used to examine the association between XRCC1 polymorphism and HNC risk. The current meta-analysis used the following statistical models, the allelic genetic model, the codominant genetic model (homozygote comparison), and the recessive genetic model. Heterogeneity among the studies was assessed using the chi-square-based Q statistic (P\<0.1 for the Q test indicates significant heterogeneity) \[[@B17]\]. We also quantified the effect of heterogeneity using the I^2^ statistic \[[@B18]\]. Either the random-effects model (DerSimonian-Laird method \[[@B19]\]) or the fixed-effects model (Mantel-Haenszel method \[[@B20]\]) was used to calculate pooled effect estimates in the presence or absence of heterogeneity, respectively. Finally, potential publication bias was evaluated through Begg's test and Egger's test by visual analysis of the funnel plot \[[@B21],[@B22]\]. P\< 0.05 was considered statistically significant publication bias. Genotype frequencies in the control populations according to race were calculated and tests on the equality of proportions was performed for the Asian and Caucasian control populations in order to compare differences in genotype frequencies between the two groups. All statistical analyses were performed with the STATA version 10.0 software (Stata Corporation, College Station, TX).

Results {#s3}
=======

Studies characteristics {#s3.1}
-----------------------

As shown in [Figure 1](#pone-0074059-g001){ref-type="fig"}, the computerized search using the search strategy mentioned above delivered 38 publications. Of these, two papers were excluded due to the fact that they did not evaluate the association between HNC risk and XRCC1 polymorphisms \[[@B23],[@B24]\]. Subsequently, five studies were excluded because of the lack of useful genotype data \[[@B25]--[@B29]\]. In the remaining 31 studies, two papers were excluded because of overlapping data \[[@B30],[@B31]\]. Ultimately, 29 studies were identified as eligible and they were analyzed \[[@B11]--[@B15],[@B32]--[@B55]\].

![Flow diagram of articles selection process.](pone.0074059.g001){#pone-0074059-g001}

In total, 29 reports, consisting of 6,719 cases and 9,627 controls, matching the inclusion criteria were included in the present meta-analysis. The characteristics are summarized in [Table 1](#pone-0074059-t001){ref-type="table"}. Of those 29 reports, 15 studies were performed on Caucasians, 10 studies were performed on Asians, and four studies were performed on a mixed population. In the 29 studies, 23 focused on the relationship between XRCC1 Arg194Trp polymorphism and HNC risk, 11 focused on Arg280His polymorphism, and 28 investigated the association between Arg399Gln polymorphism and HNC risk. In 19 studies, the controls were from a healthy population and in eight studies the controls were from a hospital population.

10.1371/journal.pone.0074059.t001

###### Main characteristics of studies included in the meta-analysis.

  First author (year)                 Country        Ethnicity   Control source   Tumor Sites                               Genotyping Methods   Sample size (case/control)   Research of environmental factors
  ----------------------------------- -------------- ----------- ---------------- ----------------------------------------- -------------------- ---------------------------- --------------------------------------
  Sturgis et al.(1999)                USA            Caucasian   Hospital         Oral cavity, larynx, oro/hypo-pharynx     PCR-RFLP             203/424                      NR
  Olshan et al.(2002)                 USA            Caucasian   Hospital         Oral cavity, larynx, pharynx              PCR-RFLP             98/161                       Smoking
  Varzim et al.(2003)                 Portugal       Caucasian   Healthy          Larynx                                    PCR-RFLP             88/178                       NR
  Cho et al.(2003)                    Taiwan         Asian       Healthy          Nasopharynx                               PCR-RFLP             334/282                      NR
  Tae et al.(2004)                    Korea          Asian       Hospital         Oral cavity, larynx, oro/hypo-pharynx     Sequence             129/157                      NR
  Demokan et al.(2005)                Turkey         Other       Healthy          NR                                        PCR-RFLP             95/98                        Smoking, alcohol
  Matullo et al.(2005)                Europe         Caucasian   Healthy          Oral cavity, larynx, pharynx              Taqman               82/1094                      Smoking
  Rydzanicz et al.(2005)              Poland         Caucasian   Healthy          Oral cavity, tongue, larynx and pharynx   PCR-RFLP             182/143                      Smoking
  Gajecka et al.(2005)                Poland         Caucasian   Healthy          Larynx                                    PCR-RFLP             293/319                      NR
  Kietthubthew et al. (2006)          Thailand       Asian       Healthy          Oral cavity                               PCR-RFLP             106/164                      Smoking
  Ramachandran et al. (2006)          India          Asian       Hospital         Oral cavity                               PCR-RFLP             110/110                      Smoking, alcohol, betel quid chewing
  Cao et al.(2006)                    China          Asian       Healthy          Nasopharynx                               PCR-RFLP             425/501                      Smoking
  Li et al.(2007)                     USA            Caucasian   Healthy          Oral cavity, larynx, pharynx              PCR-RFLP             830/854                      Smoking, alcohol
  Majumder et al.(2007)               India          Asian       Hospital         Oral cavity                               PCR-RFLP             309/385                      NR
  Yang et al.(2007)                   China          Asian       Healthy          Nasopharynx                               PCR-RFLP             153/168                      NR
  Ho et al.(2007)                     USA            Caucasian   Hospital         Oral cavity                               PCR-RFLP             138/503                      NR
  Harth et al.(2008)                  Germany        Caucasian   Hospital         Oral cavity, larynx, pharynx              PCR-RFLP             310/300                      Smoking
  Yen et al.(2008)                    Taiwan         Asian       Hospital         Oral cavity                               PCR-RFLP             103/98                       NR
  Csejtei et al.(2009)                Hungary        Caucasian   Healthy          Oral cavity, larynx, pharynx              PCR-RFLP             108/102                      Smoking
  Kowalski et al.(2009)               Poland         Caucasian   Healthy          Oral cavity, larynx, pharynx              PCR-RFLP             92/124                       Smoking
  Applebaum et al. (2009)             USA            Caucasian   Healthy          Oral cavity, larynx, oro/hypo-pharynx     PCR-RFLP             483/547                      Smoking
  Jelonek et al.(2010)                Poland         Caucasian   Healthy          NR                                        PCR-RFLP             104/252                      NR
  Gugatschka et al.(2011)             Austria        Caucasian   Healthy          NR                                        Taqman               168/463                      NR
  Laantri et al.(2011)                Morocco        African     NR               Nasopharynx                               Taqman               512/477                      NR
  Kumar et al.(2012)                  India          Asian       Healthy          Oral cavity, tongue, larynx and pharynx   PCR-RFLP             278/278                      Smoking, alcohol, tobacco chewing
  Yuan et al.(2012)                   China          Asian       Healthy          Oral cavity, larynx, oropharynx           Taqman               390/886                      NR
  Al-Hadyan et al. (2012)             Saudi Arabia   Other       Healthy          Nasopharynx                               Sequence             156/251                      NR
  Dos Reis et al.(2012)               Brazil         Other       Healthy          Oral cavity                               PCR-RFLP             150/150                      NR
  Kostrzewska-Poczekaj et al.(2012)   Poland         Caucasian   NR               Oral cavity, larynx                       PCR-RFLP             290/158                      NR

Abbreviations:NR= not reported; PCR-RFLP= PCR-based restriction fragment length polymorphism

The distribution of XRCC1 Arg194Trp, XRCC1 Arg280His, and XRCC1 Arg399Gln polymorphism genotype frequencies between the HNC cases and the controls in the 29 studies are shown in [Table 2](#pone-0074059-t002){ref-type="table"}. Noticeably, genotype distribution in the controls of Arg194Trp polymorphism in the study by Demokan et al. \[[@B36]\] and Arg399Gln polymorphism in the study by Dos Reis et al. \[46\] deviate from HWE, which are excluded in the subgroup analyses.

10.1371/journal.pone.0074059.t002

###### Distribution of XRCC1 genotypes among head and neck cancer cases and controls included in the meta-analysis.

  Gene Polymorphism                 First author (year)                  Cases (n)   Controls (n)   P-value of HWE in controls                                 
  --------------------------------- ------------------------------------ ----------- -------------- ---------------------------- --------- --------- --------- -------
  XRCC1-Arg194Trp                                                        Arg/Arg     Arg/Trp        Trp/Trp                      Arg/Arg   Arg/Trp   Trp/Trp   
                                    Sturgis et al. (1999)                180         22             1                            363       61        0         0.279
                                    Olshan et al. (2002)                 82          16             0                            135       26        0         0.537
                                    Varzim et al. (2003)                 80          8              0                            160       18        0         0.777
                                    Tae et al. (2004)                    59          52             9                            101       39        5         0.879
                                    Matullo et al. (2005)                78          4              0                            951       141       2         0.391
                                    Rydzanicz et al. (2005)              165         16             1                            129       14        0         0.827
                                    Gajecka et al. (2005)                262         27             1                            291       33        1         0.998
                                    Kietthubthew et al. (2006)           40          50             16                           77        67        20        0.664
                                    Ramachandran et al. (2006)           66          37             7                            90        19        1         0.999
                                    Cao et al. (2006)                    232         166            19                           235       217       43        0.776
                                    Majumder et al. (2007)               248         58             3                            317       62        8         0.074
                                    Yang et al. (2007)                   62          79             12                           99        65        4         0.204
                                    Ho et al. (2007)                     108         29             0                            433       69        1         0.592
                                    Harth et al. (2008)                  217         40             1                            259       39        2         0.924
                                    Yen et al. (2008)                    48          40             15                           54        35        9         0.643
                                    Csejtei et al. (2009)                96          11             1                            85        15        2         0.425
                                    Kowalski et al. (2009)               71          21             0                            102       22        0         0.556
                                    Applebaum et al. (2009)              427         55             2                            485       61        3         0.776
                                    Gugatschka et al. (2011)             148         20             0                            397       63        3         0.959
                                    Laantri et al. (2011)                492         55             4                            470       41        1         0.994
                                    Kumar et al. (2012)                  144         111            23                           121       131       26        0.535
                                    Dos Reis et al. (2012)               127         23             0                            123       24        3         0.396
  XRCC1-Arg280His                                                        Arg/Arg     Arg/His        His/His                      Arg/Arg   Arg/His   His/His   
                                    Cho et al. (2003)                    275         55             2                            215       66        2         0.442
                                    Tae et al. (2004)                    113         21             1                            139       29        0         0.473
                                    Ramachandran et al. (2006)           77          31             2                            83        26        1         0.798
                                    Majumder et al. (2007)               225         79             3                            297       87        3         0.461
                                    Yang et al. (2007)                   125         27             1                            131       35        2         0.981
                                    Ho et al. (2007)                     125         13             0                            453       50        0         0.503
                                    Harth et al. (2008)                  283         28             1                            270       30        0         0.660
                                    Applebaum et al. (2009)              437         46             1                            492       52        4         0.150
                                    Gugatschka et al. (2011)             159         9              0                            430       32        1         0.885
                                    Laantri et al. (2011)                431         114            10                           405       92        9         0.382
                                    Kumar et al. (2012)                  129         123            26                           142       116       20        0.855
  XRCC1- Arg399Gln                                                       Arg/Arg     Arg/Gln        Gln/Gln                      Arg/Arg   Arg/Gln   Gln/Gln   
                                    Sturgis et al. (1999)                94          77             32                           181       197       46        0.782
                                    Olshan et al. (2002)                 45          50             3                            62        82        17        0.412
                                    Varzim et al. (2003)                 37          40             11                           80        80        18        0.954
                                    Cho et al. (2003)                    174         128            32                           152       109       21        0.972
                                    Tae et al. (2004)                    69          51             9                            86        64        7         0.517
                                    Demokan et al. (2005)                42          41             12                           39        46        13        0.995
                                    Matullo et al. (2005)                34          38             10                           484       482       128       0.892
                                    Rydzanicz et al. (2005)              63          98             21                           59        63        21        0.825
                                    Gajecka et al. (2005)                106         153            34                           124       145       50        0.783
                                    Kietthubthew et al. (2006)           55          45             6                            67        74        23        0.940
                                    Ramachandran et al. (2006)           46          48             16                           73        33        4         0.996
                                    Cao et al. (2006)                    241         152            32                           270       201       30        0.651
                                    Li et al. (2007)                     335         374            121                          360       385       109       0.929
                                    Majumder et al. (2007)               134         143            32                           170       179       36        0.523
                                    Yang et al. (2007)                   93          54             6                            95        67        6         0.370
                                    Ho et al. (2007)                     61          62             15                           220       216       67        0.486
                                    Harth et al. (2008)                  114         166            30                           143       121       36        0.423
                                    Csejtei et al. (2009)                50          47             11                           53        41        8         0.999
                                    Kowalski et al. (2009)               37          44             11                           49        53        22        0.521
                                    Applebaum et al. (2009)              192         229            62                           232       246       69        0.956
                                    Jelonek et al.(2010)                 47          50             7                            103       124       25        0.374
                                    Gugatschka et al. (2011)             70          74             24                           204       198       61        0.503
                                    Laantri et al. (2011)                274         193            45                           279       163       35        0.268
                                    Kumar et al. (2012)                  128         124            26                           98        144       36        0.323
                                    Yuan et al. (2012)                   221         146            23                           481       339       66        0.842
                                    Al-Hadyan et al. (2012)              96          50             10                           135       99        17        0.980
                                    Kostrzewska-Poczekaj et al. (2012)   110         154            26                           50        81        27        0.837
  Arg194Trp influenced by smoking                                        Arg/Arg     Arg/Trp        Trp/Trp                      Arg/Arg   Arg/Trp   Trp/Trp   
                                    Olshan et al. (2002)                 74          16             0                            81        16        0         0.675
                                    Rydzanicz et al. (2005)              165         16             1                            129       14        0         0.827
                                    Cao et al. (2006)                    154         108            9                            78        62        14        0.947
                                    Csejtei et al. (2009)                96          11             1                            85        15        2         0.425
                                    Kowalski et al. (2009)               49          17             0                            44        8         0         0.835
  Arg399Gln influenced by smoking                                        Arg/Arg     Arg/Gln        Gln/Gln                      Arg/Arg   Arg/Gln   Gln/Gln   
                                    Rydzanicz et al. (2005)              63          98             21                           59        63        21        0.825
                                    Cao et al. (2006)                    156         102            21                           85        60        12        0.953
                                    Csejtei et al. (2009)                50          47             11                           53        41        8         0.999
                                    Kowalski et al. (2009)               19          36             11                           36        16        0         0.423

Abbreviations: HWE= Hardy--Weinberg equilibrium.

Meta-analysis results {#s3.2}
---------------------

The overall results of the meta-analysis for XRCC1 polymorphism and the risk of HNC are shown in [Table 3](#pone-0074059-t003){ref-type="table"}.

10.1371/journal.pone.0074059.t003

###### Results of meta-analysis for XRCC1 polymorphism and the risk of HNC.

  Comparison                          Number of studies      Sample size (case/control)   Test of association   Test of heterogeneity   Publication bias                                       
  ----------------------------------- ---------------------- ---------------------------- --------------------- ----------------------- ------------------ --- ------- ------- ------- ------- -------
  **Arg194Trp**                                                                                                                                                                                
  *Arg194 allele vs. Trp194 allele*                                                                                                                                                            
  Total                               22                     4,478/6,873                  0.91                  0.77-1.08               0.279              R   66.78   0.000   68.6%   0.367   0.449
  Caucasian                           12                     2,190/4,366                  1.04                  0.89-1.21               0.652              F   12.28   0.304   10.4%   0.086   0.108
  Asian                               8                      1,596/1,845                  0.76                  0.55-1.05               0.095              R   50.48   0.000   86.1%   0.019   0.001
  OC                                  6                      915/1,412                    0.74                  0.55-1.01               0.054              R   13.99   0.016   64.3%   0.452   0.573
  Smoking                             5                      717/548                      1.19                  0.94-1.52               0.155              F   4.83    0.305   17.2%   0.221   0.219
  Publication year                    4                      1147/1403                    1.11                  0.93-1.34               0.251              F   5.95    0.114   49.6%   1.000   0.890
  PCR-RFLP                            18                     3566/4659                    0.92                  0.77-1.09               0.332              R   49.24   0.000   65.5%   0.820   0.176
  Taqman                              3                      801/2069                     1.21                  0.63-2.35               0.768              R   7.65    0.022   73.9%   0.296   0.221
  *Arg/Arg vs. Trp/Trp*                                                                                                                                                                        
  Total                               22                     4,478/6,873                  0.80                  0.50-1.28               0.349              R   33.77   0.013   46.7%   0.944   0.245
  Caucasian                           12                     2,190/4,366                  1.04                  0.45-2.40               0.920              F   2.95    0.937   0.0%    0.118   0.125
  Asian                               8                      1,596/1,845                  0.70                  0.37-1.35               0.294              R   27.71   0.000   74.7%   0.035   0.046
  OC                                  6                      915/1,412                    0.71                  0.44-1.13               0.145              F   8.40    0.136   40.4%   1.000   0.715
  Smoking                             5                      717/548                      2.53                  1.16-5.53               0.020              F   1.38    0.502   0.0%    0.296   0.346
  Publication year                    4                      1147/1403                    1.33                  0.77-2.28               0.308              F   3.55    0.314   15.5%   0.308   0.908
  PCR-RFLP                            18                     3566/4659                    0.90                  0.54-1.50               0.684              R   27.70   0.016   49.5%   0.621   0.334
  Taqman                              3                      801/2069                     0.59                  0.16-2.22               0.439              F   1.55    0.461   0.0%    1.000   0.525
  *Arg/Arg vs.Arg/Trp+ Trp/Trp*                                                                                                                                                                
  Total                               22                     4,478/6,873                  0.90                  0.75-1.08               0.225              R   61.79   0.000   66.0%   0.693   0.450
  Caucasian                           12                     2,190/4,366                  1.03                  0.88-1.21               0.711              F   13.22   0.279   16.8%   0.086   0.112
  Asian                               8                      1,596/1,845                  0.72                  0.50-1.06               0.094              R   45.55   0.000   84.6%   0.019   0.003
  OC                                  6                      915/1,412                    0.70                  0.52-0.95               0.022              R   10.66   0.059   53.1%   1.000   0.483
  Smoking                             6                      842/705                      1.57                  0.68-3.64               0.289              R   44.81   0.000   88.8%   0.452   0.948
  Publication year                    4                      1147/1403                    1.13                  0.91-1.40               0.283              F   5.53    0.137   45.7%   0.734   0.852
  PCR-RFLP                            18                     3566/4659                    0.90                  0.75-1.10               0.305              R   44.93   0.000   62.2%   0.940   0.156
  Taqman                              3                      801/2069                     1.22                  0.63-2.33               0.704              R   6.88    0.032   70.9%   0.296   0.169
  **Arg280His**                                                                                                                                                                                
  *Arg280 allele vs. His280 allele*                                                                                                                                                            
  Total                               11                     2,972/3,714                  0.98                  0.87-1.10               0.757              F   9.87    0.452   0.0%    0.276   0.153
  Caucasian                           4                      1,102/1,804                  1.12                  0.86-1.45               0.411              F   0.42    0.937   0.0%    0.734   0.508
  Asian                               6                      1,315/1,394                  0.97                  0.83-1.13               0.696              F   8.00    0.156   37.5%   0.452   0.550
  OC                                  3                      555/1,000                    0.86                  0.67-1.10               0.241              F   0.59    0.746   0.0%    1.000   0.749
  Publication year                    3                      1001/1247                    0.89                  0.75-1.07               0.220              F   1.48    0.477   0.0%    0.296   0.097
  PCR-RFLP                            8                      2114/2577                    0.99                  0.87-1.14               0.922              F   8.48    0.292   17.4%   0.711   0.413
  Taqman                              2                      723/969                      0.94                  0.73-1.20               0.617              F   1.21    0.272   17.2%   1.000   
  *Arg/Arg vs.His/His*                                                                                                                                                                         
  Total                               11                     2,972/3,714                  0.84                  0.55-1.29               0.427              F   3.73    0.928   0.0%    0.721   0.638
  Caucasian                           4                      1,102/1,804                  1.56                  0.38-6.41               0.536              F   1.42    0.492   0.0%    1.000   0.276
  Asian                               6                      1,315/1,394                  0.74                  0.44-1.24               0.250              F   1.44    0.920   0.0%    0.707   0.826
  OC                                  3                      555/1,000                    0.65                  0.17-2.44               0.521              F   0.11    0.741   0.0%    1.000   
  Publication year                    3                      1001/1247                    0.78                  0.47-1.30               0.342              F   0.36    0.836   0.0%    1.000   0.559
  PCR-RFLP                            8                      2114/2577                    0.83                  0.50-1.37               0.463              F   3.13    0.792   0.0%    1.000   0.404
  Taqman                              2                      723/969                      0.97                  0.40-2.32               0.943              F   0.01    0.930   0.0%    1.000   
  *Arg/Arg vs. Arg/His + His/His*                                                                                                                                                              
  Total                               11                     2,972/3,714                  0.99                  0.87-1.13               0.872              F   9.95    0.445   0.0%    0.276   0.205
  Caucasian                           4                      1,102/1,804                  1.10                  0.84-1.44               0.483              F   0.34    0.952   0.0%    0.308   0.258
  Asian                               6                      1,315/1,394                  0.99                  0.83-1.18               0.913              F   8.26    0.142   39.5%   0.452   0.680
  OC                                  3                      555/1,000                    0.85                  0.65-1.12               0.247              F   0.61    0.736   0.0%    1.000   0.746
  Publication year                    3                      1001/1247                    0.88                  0.72-1.09               0.252              F   1.38    0.502   0.0%    1.000   0.200
  PCR-RFLP                            8                      2114/2577                    1.01                  0.86-1.17               0.938              F   8.41    0.298   16.8%   0.536   0.596
  Taqman                              2                      723/969                      0.92                  0.70-1.21               0.565              F   1.16    0.282   13.7%   1.000   
  **Arg399Gln**                                                                                                                                                                                
  *Arg399 allele vs. Gln399 allele*                                                                                                                                                            
  Total                               27                     6,466/9,379                  1.01                  0.94-1.09               0.850              R   50.97   0.002   49.0%   0.532   0.529
  Caucasian                           14                     2,639/4,768                  1.00                  0.93-1.08               0.965              F   14.09   0.368   7.7%    0.511   0.324
  Asian                               9                      2,234/2,931                  1.01                  0.84-1.21               0.931              R   30.42   0.000   73.7%   0.466   0.425
  OC                                  4                      663/1,162                    0.91                  0.59-1.40               0.674              R   22.41   0.000   86.6%   1.000   0.685
  Smoking                             4                      635/454                      0.70                  0.43-1.15               0.158              R   18.19   0.000   83.5%   0.089   0.042
  Publication year                    7                      1898/2765                    1.12                  0.96-1.29               0.149              R   14.08   0.029   57.4%   0.764   0.276
  PCR-RFLP                            21                     5029/6051                    1.02                  0.93-1.11               0.737              R   44.77   0.001   55.3%   0.566   0.558
  Taqman                              4                      1152/2920                    0.96                  0.85-1.08               0.478              F   3.73    0.292   19.6%   1.000   0.762
  Sequence                            2                      285/408                      1.08                  0.85-1.39               0.519              F   1.56    0.212   35.8%   1.000   
  *Arg/Arg vs.Gln/Gln*                                                                                                                                                                         
  Total                               27                     6,466/9,379                  1.03                  0.88-1.20               0.714              R   43.00   0.019   39.5%   0.260   0.330
  Caucasian                           14                     2,639/4,768                  1.08                  0.92-1.28               0.348              F   16.57   0.219   21.6%   0.324   0.157
  Asian                               9                      2,234/2,931                  0.97                  0.65-1.44               0.874              R   22.86   0.004   65.0%   0.466   0.478
  OC                                  4                      663/1,162                    0.91                  0.38-2.20               0.838              R   15.87   0.001   81.1%   0.806   0.692
  Smoking                             4                      635/454                      0.73                  0.33-1.63               0.445              R   7.49    0.058   60.0%   0.089   0.002
  Publication year                    7                      1898/2765                    1.28                  0.93-1.75               0.129              R   11.32   0.079   47.0%   0.230   0.314
  PCR-RFLP                            21                     5029/6051                    1.06                  0.87-1.30               0.534              R   39.18   0.006   49.0%   0.156   0.290
  Taqman                              4                      1152/2920                    0.95                  0.73-1.24               0.709              F   2.58    0.460   0.0%    0.734   0.974
  Sequence                            2                      285/408                      0.94                  0.50-1.77               0.843              F   0.96    0.328   0.0%    1.000   
  *Arg/Arg vs. Arg/Gln +Gln/Gln*                                                                                                                                                               
  Total                               27                     6,466/9,379                  0.99                  0.90-1.09               0.869              R   46.67   0.008   44.3%   0.677   0.721
  Caucasian                           14                     2,639/4,768                  0.94                  0.85-1.04               0.233              F   14.54   0.337   10.6%   0.381   0.380
  Asian                               9                      2,234/2,931                  1.04                  0.85-1.28               0.687              R   23.77   0.003   66.3%   0.917   0.472
  OC                                  4                      663/1,162                    0.88                  0.55-1.42               0.612              R   15.80   0.001   81.0%   1.000   0.657
  Smoking                             7                      1,039/746                    0.73                  0.45-1.19               0.206              R   35.56   0.000   83.1%   0.230   0.038
  Publication year                    7                      1898/2765                    1.13                  0.94-1.36               0.199              R   12.65   0.049   52.6%   0.764   0.225
  PCR-RFLP                            21                     5029/6051                    0.99                  0.89-1.12               0.928              R   40.73   0.004   50.9%   0.833   0.795
  Taqman                              4                      1152/2920                    0.94                  0.81-1.09               0.412              F   2.95    0.400   0.0%    0.734   0.734
  Sequence                            2                      285/408                      1.17                  0.86-1.59               0.308              F   1.37    0.242   27.1%   1.000   

Abbreviations: CI, confidence interval; OR, odds ratio; OC, oral cancer; R: random-effects model; F: fixed-effects model.

### XRCC1 Arg194Trp polymorphism on HNC risk in total population {#s3.2.1}

A total of 22 studies, including 4,487 cases and 6,873 controls, examining the association between XRCC1 Arg194Trp polymorphism and HNC risk were reviewed. There was significant difference in the frequency of the XRCC1 Arg194Trp polymorphism between Caucasians and Asians (34.42% vs. 12.27%, P\<0.001). The pooled ORs for total population showed no evidence of a significant association between the variant genotypes of XRCC1 Arg194Trp and the risk of HNC in any genetic model. Significant heterogeneity was found in all genetic models. The forest plot is shown in [Figure 2](#pone-0074059-g002){ref-type="fig"}.

![Forest plot of HNC risk associated with XRCC1 Arg194Trp gene polymorphism under all genetic models in total population.](pone.0074059.g002){#pone-0074059-g002}

### XRCC1 Arg194Trp polymorphism on HNC risk in a specific population {#s3.2.2}

Stratified analysis by ethnicity was performed in order to determine the source of heterogeneity among the studies. No significant association of HNC risk with XRCC1 Arg194Trp polymorphism was detected in Asians and Caucasians under any genetic model ([Figures S1-S2](#pone.0074059.s001){ref-type="supplementary-material"}). Significant differences between-study heterogeneities were found in the Asians, but they were not found in the Caucasians.

Oral cancer (OC) is the most common form of HNC and it is responsible for more than 90% of head and neck cancers \[[@B56]\]. Consequently, we performed a stratified analysis to investigate the relationship between XRCC1 Arg194Trp polymorphism and OC susceptibility. Six studies, including 915 cases and 1,412 controls, evaluating the association between OC risk and XRCC1 variant genotypes were included ([Table 1](#pone-0074059-t001){ref-type="table"}). No significant association between the XRCC1 Arg194Trp polymorphism and risk of OC was found in the allelic genetic model and the homozygote comparison, but a significant association was found for the recessive model ([Figure S3](#pone.0074059.s003){ref-type="supplementary-material"}). Between-study heterogeneities were detected in the allelic genetic model and the recessive model, but it was not found to be significant in the homozygote comparison.

Many studies have demonstrated that the interaction between XRCC1 polymorphism and environmental toxins could influence the risk of HNC. Considering that smoking is a major aspect of environmental toxins, we performed a subgroup analysis of six studies to investigate the influence that the interaction of tobacco smoke with XRCC1 polymorphism has on HNC risk. There was a significant association between the joint effect of smoking with XRCC1 Arg194Trp polymorphism and the risk of HNC under homozygote comparison ([Figure 3](#pone-0074059-g003){ref-type="fig"}). No significant association was observed in the allelic genetic model and the recessive model ([Figure 3](#pone-0074059-g003){ref-type="fig"}). Heterogeneity among the studies was not remarkable in any genetic model, except for the recessive model.

![Forest plot of HNC risk associated with interaction between XRCC1 Arg194Trp polymorphism and smoking under all genetic models.](pone.0074059.g003){#pone-0074059-g003}

Flores-Obando et al. conducted a similar meta-analysis that included studies published before 2010. Considering the inconsistent results between the two studies, we decided to perform a stratified analysis by including studies published after 2010. The result showed no significant association was detected between Arg194Trp polymorphism and HNC risk in any genetic model ([Figure S4](#pone.0074059.s004){ref-type="supplementary-material"}). Between-study heterogeneity was not remarkable in this stratified analysis.

The different genotyping methods used in the literature could cause the different genotyping results. Therefore, we performed a subgroup analysis by genotyping methods to investigate the relationship between Arg194Trp and HNC susceptibility. Neither the PCR-RFLP subgroup nor the TaqMan subgroup detected any significant association in the analyses for all genetic models ([Figures S5-S6](#pone.0074059.s005){ref-type="supplementary-material"}). Moreover, heterogeneity among the studies was observed in the two stratified analyses under all genetic models, except for the homozygote comparison in the TaqMan subgroup.

### XRCC1 Arg280His polymorphism on HNC risk in total population {#s3.2.3}

Eleven studies, including 2,972 cases and 3,714 controls, examining the relationship between XRCC1 Arg280His polymorphism and HNC risk were reviewed. There was significant difference in the frequency of the XRCC1 Arg280His polymorphism between Caucasians and Asians (25.75% vs. 9.04%, P\<0.001). There was no significant association of HNC risk with variant genotypes of XRCC1 Arg280His in any genetic model. Significant between-study heterogeneity was absence in all genetic models. The forest plot is shown in [Figure 4](#pone-0074059-g004){ref-type="fig"}.

![Forest plot of HNC risk associated with XRCC1 Arg280His gene polymorphism under all genetic models in total population.](pone.0074059.g004){#pone-0074059-g004}

### XRCC1 Arg280His polymorphism on HNC risk in specific a population {#s3.2.4}

We conducted subgroup analyses by ethnicity, tumor site, publication year, and genotyping method to estimate the relationship between XRCC1 Arg280His variant genotypes and the risk of NHC. However, no significant association was observed in any subgroup under different genetic models, and there was no significant heterogeneity among the studies in any stratified analysis ([Figures S7-S12](#pone.0074059.s007){ref-type="supplementary-material"}). Only one study evaluated the influence of the interaction between smoking and Arg280His polymorphism on HNC risk; however, we are unable to conduct a further stratified analysis of that study.

### XRCC1 Arg399Gln polymorphism on HNC risk in total population {#s3.2.5}

There were 27 studies, including 6,466 cases and 9,379 controls, that examined the association between HNC susceptibility and XRCC1 Arg399Gln polymorphism. There was significant difference in the frequency of the XRCC1 Arg399Gln polymorphism between Caucasians and Asians (41.28% vs. 44.65%, P=0.004). Overall, the association between variant genotypes of XRCC1 Arg399Gln polymorphism and HNC susceptibility was not significant under the allelic genetic model, homozygote comparison, and the recessive model. Between-study heterogeneity was detected in all genetic models. The forest plot is shown in [Figure 5](#pone-0074059-g005){ref-type="fig"}.

![Forest plot of HNC risk associated with XRCC1 Arg399Gln gene polymorphism under all genetic models in total population.](pone.0074059.g005){#pone-0074059-g005}

### XRCC1 Arg399Gln polymorphism on HNC risk in a specific population {#s3.2.6}

In the subgroup analysis by ethnicity, no significant association between XRCC1 Arg399Gln polymorphism and HNC risk was found in Asians ([Figure S13](#pone.0074059.s013){ref-type="supplementary-material"}) and Caucasians ([Figure S14](#pone.0074059.s014){ref-type="supplementary-material"}). Heterogeneity among the studies was not remarkable in Caucasians; however, significant heterogeneity was detected in Asians under all genetic models.

Four studies, including 663 cases and 1,162 controls, were performed on OC population, and there was no significant association between XRCC1 Arg399Gln polymorphism and HNC susceptibility ([Figure S15](#pone.0074059.s015){ref-type="supplementary-material"}). Between-study heterogeneity was found in all genetic models.

In the stratified analysis by smoking in the allelic genetic model and homozygote comparison, four studies were included and no significant association was found ([Figure S16](#pone.0074059.s016){ref-type="supplementary-material"}). Seven studies were combined in the recessive model. However, we failed to derive a significant association between HNC risk and Arg399Gln genotype ([Figure S16](#pone.0074059.s016){ref-type="supplementary-material"}). Heterogeneity among the studies was observed in all genetic models.

In stratified analysis by publication year of literature published from 2010--2012, significant heterogeneity was detected in all genetic models. Moreover, we found no association between Arg399Gln and HNC risk under any genetic model ([Figure S17](#pone.0074059.s017){ref-type="supplementary-material"}).

In subgroup analysis of genotyping method, PCR-RFLP, TaqMan, and sequence analysis were used in the literature for genotyping of XRCC1 Arg399Gln polymorphism. The results showed no significant association between Arg399Gln and HNC risk in any stratified analysis under different genetic models ([Figures S18-S20](#pone.0074059.s018){ref-type="supplementary-material"}).

Publication bias {#s3.3}
----------------

Both Begg's test and Egger's test were performed to assess the publication bias of the literature. Visual analysis of the funnel plots did not present any evidence of obvious asymmetry for any genetic model in the overall meta-analyses of XRCC1 Arg194Trp, Arg280His, and Arg399Gln ([Figures 6-8](#pone-0074059-g006){ref-type="fig"}). However, obvious evidence of publication bias was revealed in the XRCC1 Arg194Trp Asian group under all genetic models. In XRCC1 Arg399Gln smoking stratified analysis, potential publication bias was not revealed in Begg's test under any genetic model, but it was presented in the Egger's test. Neither the Begg's test nor the Egger's test detected any obvious evidence of publication bias in other stratified analyses for all genetic models ([Table 3](#pone-0074059-t003){ref-type="table"}).

![Funnel plot for studies of the association of HNC risk and XRCC1 Arg194Trp gene polymorphism under an allelic genetic model.](pone.0074059.g006){#pone-0074059-g006}

![Funnel plot for studies of the association of HNC risk and XRCC1 Arg280His gene polymorphism under an allelic genetic model.](pone.0074059.g007){#pone-0074059-g007}

![Funnel plot for studies of the association of HNC risk and XRCC1 Arg399Gln gene polymorphism under an allelic genetic model.](pone.0074059.g008){#pone-0074059-g008}

Discussion {#s4}
==========

DNA repair mechanisms play a critical role in the protection of cells from DNA damage and in the maintenance of genomic integrity. The protein encoded by the XRCC1 gene is a scaffolding protein that associates with DNA ligase I, DNA ligase III, polynucleotide kinase (PNK), DNA polymerase β, and poly polymerase, which are parts of the DNA repair system. The interaction of XRCC1 with DNA ligase III could increase the endocellular stability of ligase. The joint effects of XRCC1 and PNK stimulate the 5'-kinase and 3'-phospatase activities. All of these conditions promote the repair of DNA. Therefore, sequence variation in the XRCC1 gene is suggested to alter cancer's susceptibility. The most common variant genotypes of XRCC1, including the Arg194Trp, Arg399Gln, and Arg280His genes, are described and a number of studies have investigated the genetic effect of the XRCC1 Arg194Trp, Arg280His, and Arg399Gln polymorphisms on HNC susceptibility with inconsistent results. This diversity motivates the current updated meta-analysis that may help us to explore a more robust estimate of the effect of XRCC1 polymorphism on the risk of HNC. In the present meta-analysis of 6,719 cases and 9,627 controls, no evidence of a significant association between HNC susceptibility and any type of XRCC1 variant genotype was detected.

A previous meta-analysis, conducted in 2010 by Flores-Obando et al., evaluated the relationship between XRCC1 polymorphisms and the risk of HNC based on 15 publications including 2,330 cases and 3,834 controls for Arg194Trp, four publications including 879 cases and 926 controls for Arg280His, and 15 studies including 3,582 cases and 5,347 controls for Arg399Gln polymorphism. We updated this meta-analysis by adding the sample sizes. A total of 22 studies, including 4,487 cases and 6,873 controls, evaluated the association between the XRCC1 Arg194Trp gene and HNC risk; 11 studies, including 2,972 cases and 3,714 controls, evaluated the association between Arg280His and HNC risk; and 27 studies, including 6,466 cases and 9,379 controls, evaluated the association between Arg399Gln polymorphism and HNC risk. There are some discrepancies between the Flores-Obando et al. meta-analysis and ours. A marginal association between XRCC1 Arg399Gln polymorphism and HNC risk was detected under the recessive genetic model on Caucasians in the meta-analysis conducted by Flores-Obando et al., but it was not found in ours. These diverse results may, generally, be due to the differences in the studies included in the meta-analysis. Nasopharyngeal carcinoma (NPC) is one type of HNC, which has a striking geographic and ethnic distribution, with particularly high rates observed among Asians. The literature on NPC was not included in the Flores-Obando et al. study, but it was included in ours. In the above-mentioned stratified analysis result, seven articles were shared the Flores-Obando et al. study and our study, and our study included an additional seven articles, including newly published literature and NPC literature. The results of these seven studies account for 54.94% weight ([Figure 9](#pone-0074059-g009){ref-type="fig"}), which caused the discrepancy between these two meta-analyses. In the assessment of the effect of XRCC1 Arg194Trp variant genotypes on HNC susceptibility, the meta- OR conducted by Flores-Obando et al. found a significant association between the Arg194Trp variant and HNC risk for homozygote comparison in the overall population and in the Asian group, which was not detected in our meta-analysis. Similarly, in our study, an additional nine studies and four studies, comprised of recently published research and NPC studies, included in the overall population group and the Asian group, respectively. The results of these additional studies account for 53.46% and 53.79% weight ([Figures 10-11](#pone-0074059-g008){ref-type="fig"}), respectively. In the controls in a study conducted by Demokan et al., genotype distribution in Arg194Trp deviated from HWE, which was excluded in our analysis of Arg194Trp polymorphism; however, it was included in the Flores-Obando et al. article. Furthermore, both our study and the Flores-Obando et al. study included two studies by Majumder et al. Majumder et al.'s most recent publication was included in our study, but Majumder et al.'s research published in 2005 was included in the Flores-Obando et al. meta-analysis. These factors lead to the different conclusion. Many other relationships were not described in the Flores-Obando et al. article. Moreover, we carried out some independent and original subgroup analyses. Subgroup analysis of smoking was not performed in the Flores-Obando's study, but it was included in this meta-analysis. We also conducted stratified analyses by genotyping methods and publication year, and all the results revealed no association between XRCC1 polymorphism and cancer risk. Therefore, our meta-analysis has stronger evidence to clarify the associations.

![Forest plot of HNC risk associated with XRCC1 Arg399Gln gene polymorphism under recessive genetic models on Caucasians.](pone.0074059.g009){#pone-0074059-g009}

![Forest plot of HNC risk associated with XRCC1 Arg194Trp gene polymorphism under a homozygote comparison in total population.](pone.0074059.g010){#pone-0074059-g010}

![Forest plot of HNC risk associated with XRCC1 Arg194Trp gene polymorphism under a homozygote comparison on Asians.](pone.0074059.g011){#pone-0074059-g011}

The relationship between HNC susceptibility and variant genotypes of XRCC1 might be affected by the tumor sites. Accordingly, we also performed stratified analysis in the oral cancer group. The result of this subgroup analysis showed no evidence for a significant association between XRCC1 polymorphism and the risk of OC in any genetic model, except for the Arg194Trp variant in the recessive model. These results generally agreed with the meta-analysis conducted by Zhou et al. \[[@B57]\], but there were still several differences. Two studies by Sturgis et al. \[[@B45]\] and Matullo et al. \[[@B49]\], which included oral cavity, pharynx, and larynx cancer cases, were not excluded from the Zhou et al. study. The two studies \[[@B31],[@B48]\] were conducted by the same first author and the patient population was obtained from the same hospital; as a result, there is a suspicion that the findings are a duplication of a previous publication. Therefore, only one study met the inclusion criteria to participate in our research.

Recent studies have reported on the associated risk of XRCC1 polymorphism cross lifestyle factors in the progression of head and neck cancer. Cigarette smoking is a major subject of investigation in various cancers. In 1997, the World Health Organization reported that there were 1.1 billion smokers worldwide and smoking-related cancers accounted for 22% of all cancers. Hence, subgroup analysis to estimate the interaction between the genotypes of XRCC1 Arg194Trp and Arg399Gln and smoking on HNC risk was performed. The results showed that the interaction of smoking and Arg399Gln variant genotypes displayed no statistical significance in all three genetic models. A significant association between the joint effect of smoking and XRCC1 Arg194Trp polymorphism and HNC susceptibility was detected under a homozygote comparison (OR= 2.53, 95% CI= 1.16-5.53, P= 0.020), but no statistical significance was revealed in the other genetic models. In the forest plot of HNC risk associated with the interaction between smoking and Arg194Trp, the result of a study by Cao et al. accounted for 71.15% weight ([Figure 12](#pone-0074059-g009){ref-type="fig"}), which may mean that XRCC1 Arg194Trp variants are nominally associated with HNC susceptibility in smokers even at a lenient threshold for statistical significance (P= 0.05). Hence, careful consideration is needed for the lack of signals with strong credibility that emerged from this subgroup analysis. The results suggest that XRCC1 Arg194Trp polymorphism may have a small involvement in the pathogenesis of HNC in smokers.

![Forest plot of HNC risk associated with interaction between XRCC1 Arg194Trp polymorphism and smoking under a homozygote comparison.](pone.0074059.g012){#pone-0074059-g012}

Between-study heterogeneity is a well-known problem that is unavoidable. In our meta-analysis, heterogeneity was detected in the Arg194Trp and Arg399Gln polymorphism total population groups ([Table 3](#pone-0074059-t003){ref-type="table"}). The source of heterogeneity may arise from many aspects, such as the region of study, the sample size of the case and the control group, and the genotyping method. In order to explain the main reasons for the heterogeneity across studies, stratified analyses by ethnicity and genotyping method were performed. The results showed that in both the Arg194Trp group and the Arg399Gln group, significant heterogeneity was observed in the Asian population subgroup and in the PCR-RFLP analysis subgroup under all different genetic models. This signifies that the source of total population group heterogeneity may come from different races and different genotyping methods.

Publication bias is a well-known problem that was not found by funnel plot for the overall meta-analyses of the XRCC1 polymorphisms ([Figures 6-8](#pone-0074059-g006){ref-type="fig"}). However, we found a potential publication bias in the Arg194Trp Asians stratified analysis and the Arg399Gln smoking stratified analysis. The reasons for this could arise from many aspects. For instance, our meta-analysis took into consideration only fully published studies. Positive results tend to be accepted by journals. In addition, language bias may also have existed.

Some limitations should be considered in our meta-analysis. First, some of the included studies in our meta-analysis contained a smaller sample size, which might result in a lack of ability to detect the possible risk for XRCC1 polymorphism. Second, due to the limited number of studies, subgroup analysis was not performed in Africans \[[@B12]\]. Third, this study was based on unadjusted estimates, while a more precise analysis could be performed if individual data were available.

Despite of the limitations mentioned above, the results of the current meta-analysis suggest that XRCC1 Arg194Trp, Arg280His, and Arg399Gln polymorphism is not involved in HNC susceptibility. In addition, further studies evaluating the effect of gene-gene and gene-environment interactions on these gene polymorphisms with HNC susceptibility are required, especially in an African population.
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